Fig. 4From: The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosisOverall Survival by Composite Organ and Hematologic Response. The composite hematologic and organ response (CHOR) model (Panel a). Group 1 defined by summary score of 0–3; Group 2 defined by summary score of 4–5. Overall survival in the composite model was similar in the Mayo Clinic (Panel b; p < 0.001) and Pavia (Panel c; p < 0.001) cohorts. Reproduced with permission (Sidana et al. 2017. Am Soc Hematol. 130:abstract #3046)Back to article page